Skip to main content
. 2021 Aug 4;9:20503121211037903. doi: 10.1177/20503121211037903

Table 1.

Subject characteristics.

Switched group (N = 80) Continued group (N = 57) p-value
Age (years) 48.1 ± 18.7 53.6 ± 15.9 0.07
Disease duration (years) 5.4 ± 8.6 12.5 ± 12.6 <0.001
Administration period of benzodiazepine hypnotics (years) 3.9 ± 4.8 12.4 ± 12.6 <0.001
Diazepam conversion amount of benzodiazepine hypnotics (mg) 4.6 ± 2.8 8.9 ± 4.2 <0.001